Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of SIM1910-09 in Healthy Chinese Volunteers
NCT05200728Phase 1Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cerebral edema and acute ischemic stroke (AIS) comparing SIM1910-09 with Placebo (2 arms). Primary endpoints: Adverse events, Clinically significant change from baseline of physical examinations and 3 more. Started Dec 2021; status: completed.
02
Drugs
AER-271
03
Conditions
cerebral edemaacute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT05200728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05200728.